SCHEMBL3853393

SCHEMBL3853393

Fc1cccc(F)c1-c1nn(C(c2ccccc2)(c2ccccc2)c2ccccc2)cc1-c1ccc2ncn(-c3ccc(Cl)cn3)c2c1

nearest known ligand 0.35

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 2/20 0.32
ALDH1A1 P00352 1/20 0.32
MAPT P10636 1/20 0.32
CDK9 P50750 3/20 0.31
PIK3R2 O00459 2/20 0.31
MAP3K14 Q99558 1/20 0.31
ADORA3 P0DMS8 1/20 0.30
ADORA1 P30542 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3854592 0.93 FGFR1 (0.35) ALDH1A1MAPT
SCHEMBL3850334 0.93 ALDH1A1 (0.38) ALDH1A1MAPTCDK9PIK3R2MAP3K14
SCHEMBL3845874 0.89 CDK9 (0.34) ALDH1A1MAPTCDK9
SCHEMBL3853395 0.84
SCHEMBL3850336 0.78 ALDH1A1 (0.34) ALDH1A1MAPT
SCHEMBL3849277 0.77 JAK2 (0.35) MAPK14CDK9PIK3R2
SCHEMBL3847147 0.77 FGFR1 (0.39) ALDH1A1MAPT
Hydrochloric Acid SCHEMBL3847316 0.77 MAP3K14 (0.33) MAPK14CDK9PIK3R2MAP3K14
SCHEMBL3846713 0.77 POLB (0.41) MAPK14CDK9PIK3R2ADORA1
SCHEMBL3850666 0.77 JAK2 (0.34) MAPK14CDK9PIK3R2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed